ReviewCurrent neurology and neuroscience reports2016
Sickle Cell Disease and Stroke: Diagnosis and Management.
Review in Current neurology and neuroscience reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Bright IDEAS problem-solving skills training for caregivers of children with sickle cell disease: A two-site pilot feasibility trial.Pediatric blood & cancer · 2021Trial
- Investigating Disruptions in Information Flow due to Sickle Cell Disease Using Granger Causality.Human brain mapping · 2025Article
- Abnormal Neurologic Findings in Patients With Sickle Cell Disease Without a History of Major Neurologic Events.Neurology. Clinical practice · 2024Article
- Stroke and presence of patent foramen ovale in sickle cell disease.Journal of thrombosis and thrombolysis · 2021Review
- Cerebrovascular Complications of Anemia.Current neurology and neuroscience reports · 2021Review
- A case of Sβ+ sickle cell disease diagnosed in adulthood following acute stroke: it's 2021, are we there yet?Journal of community hospital internal medicine perspectives · 2021Article
- Risk Factors for Recurrent Arterial Ischemic Stroke in Children and Young Adults.Brain sciences · 2020Review
- Neurologic Complications of Sickle Cell Disease.Current neurology and neuroscience reports · 2019Review
- Chronic organ failure in adult sickle cell disease.Hematology. American Society of Hematology. Education Program · 2017Review
- The cause of the stroke: a diagnostic uncertainty.BMJ case reports · 2017Article
- Neurological and Neurosurgical Emergencies in Patients with Hematological Disorders.Current neurology and neuroscience reports · 2017Review
- Photoacoustic Flow Cytometry for Single Sickle Cell DetectionAnalytical cellular pathology (Amsterdam) · 2016Article
- Catastrophic Neurological Complications in 2 Patients With Sickle Cell Disease and COVID-19.Journal of investigative medicine high impact case reportsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Both adult and pediatric patients with sickle cell disease face a higher risk of stroke than the general population. Given the different underlying pathophysiology predisposing these patients to stroke, providers should be aware of differences in guidelines for stroke management. This paper reviews diagnostic considerations and recommendations during the evaluation and acute management of patients with sickle cell disease presenting with stroke, focusing on recent updates in the literature. Given the high recurrence rate of stroke in these patients, secondary prevention and curative measures will also be reviewed.
Indexed as
Identifiers
26873822What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.